Here's one of those rare studies that compare the effectiveness of the biological meds against the small molecules. At least in this study, looks like small molecules are kicking biologics butts.
Lay Summary
Indirect evidence suggests Rinvoq/upadacitinib may be more efficacious than other advanced therapies at achieving clinical response, clinical remission, and endoscopic response over 1 year for moderately to severely active ulcerative colitis patients, with similar safety assessments across advanced therapies.
Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis
https://academic.oup.com/crohnscolitis360/article/5/2/otad009/7066911?login=false